Geneva Capital Management LLC Sells 36,271 Shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Geneva Capital Management LLC lessened its holdings in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 7.0% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 480,145 shares of the company’s stock after selling 36,271 shares during the quarter. Geneva Capital Management LLC owned about 0.18% of Ryan Specialty worth $30,806,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Sanctuary Advisors LLC boosted its position in Ryan Specialty by 1.2% during the fourth quarter. Sanctuary Advisors LLC now owns 15,690 shares of the company’s stock worth $1,045,000 after purchasing an additional 188 shares during the period. State of Alaska Department of Revenue boosted its position in shares of Ryan Specialty by 1.6% in the fourth quarter. State of Alaska Department of Revenue now owns 12,130 shares of the company’s stock valued at $778,000 after acquiring an additional 190 shares during the period. CIBC Asset Management Inc boosted its position in shares of Ryan Specialty by 5.6% in the fourth quarter. CIBC Asset Management Inc now owns 3,674 shares of the company’s stock valued at $236,000 after acquiring an additional 196 shares during the period. Loomis Sayles & Co. L P boosted its position in shares of Ryan Specialty by 26.3% in the third quarter. Loomis Sayles & Co. L P now owns 1,373 shares of the company’s stock valued at $91,000 after acquiring an additional 286 shares during the period. Finally, Exchange Traded Concepts LLC boosted its position in shares of Ryan Specialty by 2.6% in the fourth quarter. Exchange Traded Concepts LLC now owns 11,760 shares of the company’s stock valued at $755,000 after acquiring an additional 295 shares during the period. Institutional investors own 84.82% of the company’s stock.

Ryan Specialty Trading Up 1.1 %

RYAN stock opened at $70.77 on Thursday. The company has a market capitalization of $18.53 billion, a PE ratio of 102.56, a price-to-earnings-growth ratio of 1.19 and a beta of 0.72. Ryan Specialty Holdings, Inc. has a one year low of $48.48 and a one year high of $75.97. The company’s 50 day moving average price is $66.36 and its two-hundred day moving average price is $67.53. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01.

Ryan Specialty (NYSE:RYAN) last posted its quarterly earnings results on Thursday, February 20th. The company reported $0.45 EPS for the quarter, missing the consensus estimate of $0.47 by ($0.02). The business had revenue of $663.53 million for the quarter, compared to analysts’ expectations of $658.80 million. Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. As a group, analysts predict that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current fiscal year.

Ryan Specialty Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Tuesday, March 4th will be paid a dividend of $0.12 per share. The ex-dividend date of this dividend is Tuesday, March 4th. This is an increase from Ryan Specialty’s previous quarterly dividend of $0.11. This represents a $0.48 annualized dividend and a dividend yield of 0.68%. Ryan Specialty’s dividend payout ratio (DPR) is 69.57%.

Insiders Place Their Bets

In related news, Director Nicholas Dominic Cortezi sold 31,409 shares of Ryan Specialty stock in a transaction on Wednesday, January 29th. The shares were sold at an average price of $65.64, for a total value of $2,061,686.76. Following the transaction, the director now directly owns 2,697 shares of the company’s stock, valued at $177,031.08. The trade was a 92.09 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Over the last ninety days, insiders have sold 316,451 shares of company stock valued at $20,907,793. 11.10% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of research firms have recently commented on RYAN. Barclays raised their price objective on shares of Ryan Specialty from $76.00 to $88.00 and gave the company an “overweight” rating in a research report on Thursday, November 21st. Morgan Stanley began coverage on shares of Ryan Specialty in a research report on Thursday, December 5th. They issued an “overweight” rating and a $90.00 price objective for the company. UBS Group raised their price objective on shares of Ryan Specialty from $82.00 to $84.00 and gave the company a “buy” rating in a research report on Wednesday, February 26th. Royal Bank of Canada cut their price objective on shares of Ryan Specialty from $73.00 to $72.00 and set a “sector perform” rating for the company in a research report on Friday, February 21st. Finally, Keefe, Bruyette & Woods lowered their target price on shares of Ryan Specialty from $77.00 to $76.00 and set an “outperform” rating on the stock in a research note on Friday, February 21st. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $75.27.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.